|

| Return on Reputation is a philosophy that guides our approach to strategic communication and reputation management. Emphasizing the link between reputation and its ability to achieve business goals has been part of APCO's approach to our clients' challenges and opportunities for years. Corporate brands need to deliver value. While it has historically been easier to quantify the value of product brands, we can now quantify tangible value for corporate brands and reputations.
|
Learn More About Our Research
| |

|
|
 |
Uncovers the unique opportunities for building the reputation of the U.S. biopharmaceutical industry, based on studies among health care opinion leaders, health care providers, policy-makers and payers. | |
A deep look at the reputation of the U.S. retail sector, including more than 10,000 respondents representing consumers, community activists, policy-makers, investors and analysts, and retail employees. | |
Explores expectations and opportunities for the health insurance industry to build its reputation capital in the midst of health care reform. |
Coming Soon:
ROR: State of the APAC Pharmaceutical Industry
Isolates the key drivers that define the reputation of companies in the pharmaceutical industry in key Asia-Pacific markets through the lens of health care opinion leaders, health care providers, policy leaders and payers. The study is based on a quantitative survey conducted among more than 1,500 stakeholders in China, Japan, Korea, India and Australia. Contact Chrystine Zacherau to learn more about the progress of this study and how you can gain access to the results.